Domestic major pharmaceutical firms favors strategic partnership with promising venture

The Korea Drug Research Association (KDRA) says that its15-day survey conducted on last month disclosed that 97 percent of its 28 members polled said they would agree with the necessity of outsourcing for their R&D new drug projects and better competitiveness and promising bioventure firms would be one of the best business partners. The KDRA has further noted:

- As for the investment scope d...